4th International Conference on PharmScience Research And Development

February 22-24, 2022 | USA

4th International Conference
In 2022, get ready for more interaction and networking at 4th International Conference on PharmScience Research & Development, in-person conference. Moving pharma from bench to market will capture the attention of hundreds of scientists from around the globe as they participate in the Pharma R&D 2022, Feb 22-24, San Franscisco, CA.

Spotlight

The drug they were making was a predecessor of today’s therapies. It was complex, high-value and hard to manufacture. Seeing that pharmaceutical companies’ drug discovery platforms were swelling the ranks of clinical product candidates, they could see the conditions emerging that are clear today. There are a greater number of targeted therapies for smaller patient populations.


OTHER PAST CONFERENCES

Transforming Drug Discovery through AI 2022

July 5-6, 2022 | USA

All big players in the pharma industry are concerned with AI adoption, the tech has become a strategic priority, among other things and all leading players of the pharmaceutical industry will be moving towards "platform-based drug design"

4th International Conference on Alternative Medicine

July 15-16, 2022 | USA

Alternative & Integrative Medicine2022 is honored to extend an invitation to all notable individuals from around the world to the "4th International Conference on Alternative Medicine," which will be held as a Webinar on July 15-16, 2022.

24th Conference And Expo Pharma Manufacturing And Technology

May 31-June 1, 2022 | USA

After two years of Virtual PharmaTechnica, the PharmaCongress returns to its usual form this year - from 31 May to 1 June 2022 in Düsseldorf/Neuss.

INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES

June 6-7, 2022 | Mauritius

Welcome to the official website of from World Academics. will be held in Port Louis, Mauritius during 6th June-7th June 2022. .

Spotlight

The drug they were making was a predecessor of today’s therapies. It was complex, high-value and hard to manufacture. Seeing that pharmaceutical companies’ drug discovery platforms were swelling the ranks of clinical product candidates, they could see the conditions emerging that are clear today. There are a greater number of targeted therapies for smaller patient populations.

resources